Research only
All of alz.org
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

Corporate Symposia - non-CME

Monday, July 20, 2015
6-8:20 p.m., reception followed by program and dinner
New Directions in Alzheimer’s Disease: Treatment Approaches and Novel Mechanisms

This program will provide an overview of current therapeutic approaches in Alzheimer’s disease (AD) and identify unmet treatment needs for the growing number of people affected by AD. The potential role of novel mechanisms, including the alpha‐7 acetylcholine receptor, will also be discussed.

Location
Renaissance Washington Hotel
Renaissance Ballroom

Sponsored by:
FORUM Pharmaceuticals

RSVP

 


Monday, July 20, 2015
6-7:30 p.m., with refreshments from 5:30 p.m.
Emerging Opportunities for Intervention Early in the Alzheimer’s Disease Spectrum

The focus of our Satellite Symposium this year will be ‘moving earlier in the Alzheimer’s disease spectrum’. The session will be chaired by Dr. Jeff Cummings and will feature presentations on recent developments in the early identification of Alzheimer’s disease which present new opportunities for nutritional intervention in the prodromal phase.

Location
Marriott Marquis Hotel
Independence Room, Salons A-D

Sponsored by:
Nutricia Advanced Medical Nutrition

 


Tuesday, July 21, 2015
6-8 p.m., with light refreshments from 5:45 p.m.
Disease Modification in AD
Clinical and Pathological Progression: Where Should the Focus Be?

This interactive symposium will explore disease modification: What is it? How might it be demonstrated? Does it matter? In a debate-style format, AD experts will discuss the concept of disease modification as it relates to patients, caregivers, clinicians, researchers, payers and regulators.

Location
Marriott Marquis Hotel
Independence Room

Sponsored by:
Eli Lilly and Company

 


Tuesday, July 21, 2015
6:30 p.m.
The CPR of Amyloid Imaging: Clinical assessment, image Processing, and Reimbursement

This symposium discusses clinical cases and research studies illustrating the clinical utility of amyloid imaging in diagnosing and managing patients when clinical presentation is unusual. In addition, an overview and update on the IDEAS study, the US clinical registry using amyloid imaging will be provided.

Location
Renaissance Washington Hotel
Renaissance Ballroom

Sponsored by:
Piramal Imaging, Ltd

RSVP

 


Wednesday, July 22, 2015
6:15 p.m.
Supporting Patients in the Moderate to Severe Stages of Alzheimer’s Disease: A New Treatment Option

This symposia will review the symptoms, diagnosis and current treatments that are available and a recently approved treatment for patients with moderate to severe Alzheimer’s disease.

Location
Renaissance Washington Hotel
Renaissance Ballroom

Sponsored by:
Actavis

RSVP

 


Wednesday, July 22, 2015
5:30-8 p.m.
Towards Phase 2 of Axon’s Disease Modifying Tau Immunotherapy: First-in-Man, First-in-Class

For the first time, AXON Neuroscience will present its Phase 1 results of the pioneering tau active vaccine AADvac1. At this Symposium, AXON will also give an exclusive preview of the designs of the Phase 2 study in Alzheimer´s disease patients and the Phase 1 study in frontotemporal dementia patients.

Location
Marriott Marquis Hotel
Independence Ballroom

Sponsored by:
AXON Neuroscience

RSVP

 


Wednesday, July 22, 2015
6:30-8 p.m.
From Research to Routine Use: The Value of Imaging Biomarkers

This exciting symposium will review major achievements in the field of imaging biomarkers as well as discussing the challenges that face tau imaging in the future. We will also explore the close relationship between pathology and imaging and present data from a new study investigating the utility of 18F Flutemetamol imaging in the clinical setting.

Location
Marriott Marquis Hotel
Liberty Ballroom

Sponsored by:
GE Healthcare

RSVP

 

 



back to top
A global forum to advance dementia science • Toronto, Canada • Conference: July 22–28, 2016